Company profile POAI
After 39 days of this quarter the interest is at 104.0. Based on that we can calculate that during remaining 52 days it will total up to 243.0. predictive oncology expected interest is significantly higher compared to previous quarter (+131.4%) and same quarter last year (+72.3%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 21 | 102 385.7% QoQ | 176 72.5% QoQ | 155 -11.9% QoQ |
| 2020 | 77 266.7% YoY -50.3% QoQ | 255 150.0% YoY 231.2% QoQ | 188 6.8% YoY -26.3% QoQ | 140 -9.7% YoY -25.5% QoQ |
| 2021 | 522 577.9% YoY 272.9% QoQ | 287 12.5% YoY -45.0% QoQ | 251 33.5% YoY -12.5% QoQ | 125 -10.7% YoY -50.2% QoQ |
| 2022 | 157 -69.9% YoY 25.6% QoQ | 251 -12.5% YoY 59.9% QoQ | 144 -42.6% YoY -42.6% QoQ | 78 -37.6% YoY -45.8% QoQ |
| 2023 | 141 -10.2% YoY 80.8% QoQ | 260 3.6% YoY 84.4% QoQ | 111 -22.9% YoY -57.3% QoQ | 105 34.6% YoY -5.4% QoQ |
| 2024 | 104 -26.2% YoY -1.0% QoQ | - | - | - |
The average 5 years interest of predictive oncology was 13.98 per week. The last year interest of predictive oncology compared to the last 5 years has changed by -9.08%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 34.36%.
There is not enough data for predictive oncology predictive oncology news to provide analysis
There is not enough data for predictive oncology predictive oncology news to provide correlation calculation
There is not enough data for predictive oncology predictive oncology news to provide analysis
There is not enough data for predictive oncology stock analysis to provide analysis
There is not enough data for predictive oncology stock analysis to provide correlation calculation
There is not enough data for predictive oncology stock analysis to provide analysis
After 39 days of this quarter the interest is at 53.0. Based on that we can calculate that during remaining 52 days it will total up to 124.0. predictive oncology stock forecast expected interest is significantly higher compared to previous quarter (+67.6%) and same quarter last year (+188.4%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 72 | 0 -100.0% QoQ | 101 inf% QoQ | 103 2.0% QoQ |
| 2020 | 102 41.7% YoY -1.0% QoQ | 96 inf% YoY -5.9% QoQ | 51 -49.5% YoY -46.9% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2021 | 132 29.4% YoY inf% QoQ | 71 -26.0% YoY -46.2% QoQ | 230 351.0% YoY 223.9% QoQ | 100 inf% YoY -56.5% QoQ |
| 2022 | 120 -9.1% YoY 20.0% QoQ | 212 198.6% YoY 76.7% QoQ | 26 -88.7% YoY -87.7% QoQ | 225 125.0% YoY 765.4% QoQ |
| 2023 | 43 -64.2% YoY -80.9% QoQ | 59 -72.2% YoY 37.2% QoQ | 152 484.6% YoY 157.6% QoQ | 74 -67.1% YoY -51.3% QoQ |
| 2024 | 53 23.3% YoY -28.4% QoQ | - | - | - |
The average 5 years interest of predictive oncology stock forecast was 7.75 per week. The last year interest of predictive oncology stock forecast compared to the last 5 years has changed by -16.13%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -3.13%.
There is not enough data for predictive oncology biobank to provide analysis
There is not enough data for predictive oncology biobank to provide correlation calculation
There is not enough data for predictive oncology biobank to provide analysis
There is not enough data for predictive oncology helomics to provide analysis
There is not enough data for predictive oncology helomics to provide correlation calculation
There is not enough data for predictive oncology helomics to provide analysis
There is not enough data for predictive oncology zPREDICTA to provide analysis
There is not enough data for predictive oncology zPREDICTA to provide correlation calculation
There is not enough data for predictive oncology zPREDICTA to provide analysis
There is not enough data for predictive oncology Soluble to provide analysis
There is not enough data for predictive oncology Soluble to provide correlation calculation
There is not enough data for predictive oncology Soluble to provide analysis
There is not enough data for predictive oncology Skyline to provide analysis
There is not enough data for predictive oncology Skyline to provide correlation calculation
There is not enough data for predictive oncology Skyline to provide analysis